EICHORPublic-registry site landscape for NCT07690826, “A Study to Evaluate the Efficacy and Safety of HRS-4729 Injection in Obesity”, a Overweight or Obesity study sponsored by Fujian Shengdi Pharmaceutical Co., Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07690826 (registry record) |
| Study title | A Study to Evaluate the Efficacy and Safety of HRS-4729 Injection in Obesity |
| Official title | A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of HRS-4729 Injection in Participants With Obesity |
| Sponsor | Fujian Shengdi Pharmaceutical Co., Ltd. |
| Condition(s) | Overweight or Obesity |
| Phase | PHASE2 |
| Listed sites | 1 |
| Site countries | China |
Patient-friendly overview of this study: eichor.com/study/NCT07690826.
Eichor generates a preliminary site-risk snapshot for NCT07690826 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Overweight or Obesity trials
More from Fujian Shengdi Pharmaceutical Co., Ltd.
← Eichor home · All tracked trials · Overweight or Obesity studies · Weekly briefs
